U.S. Department of Health and Human Services
Clinical Trials Search Results
Search results 1 - 10 of 13 for Investigational HIV Drugs, Leronlimab
Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection
Condition: HIV; Human Immunodeficiency Virus
NCT ID: NCT02175680- Red stop iconCompleted
- Email this trial
PRO 140 for Human Immunodeficiency Virus Infection
Condition: HIV
NCT ID: NCT02257788- Red stop iconWithdrawn
- Email this trial
A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence
Condition: HIV
NCT ID: NCT01272258- Red stop iconWithdrawn
- Email this trial
Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers
Condition: HIV Infections
NCT ID: NCT00110591- Red stop iconCompleted
- Email this trial
A Randomized, Double-blind, Placebo-controlled Trial, Followed by Single-arm Treatment of PRO 140 in Combination w/ Optimized Background Therapy in Treatment-Experienced HIV Subjects
Condition: HIV
NCT ID: NCT02483078- Red stop iconCompleted
- Email this trial
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
Condition: HIV -1 Infection; HIV Infections
NCT ID: NCT00642707- Red stop iconCompleted
- Text file iconHas Results
- Email this trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Condition: HIV
NCT ID: NCT02859961- Green tick iconRecruiting
- Email this trial
PRO 140 for Human Immunodeficiency Virus
Condition: HIV
NCT ID: NCT02438345- Red stop iconWithdrawn
- Email this trial
PRO 140 by IV Administration in Adults With HIV-1 Infection
Condition: HIV Infections
NCT ID: NCT00613379- Red stop iconCompleted
- Text file iconHas Results
- Email this trial
An Extension of Protocol PRO 140_CD01 TS Study
Condition: HIV; Human Immunodeficiency Virus
NCT ID: NCT02355184- Red stop iconActive, not recruiting
- Email this trial
Email Updates
